About Us

Mr. Russo is the Chief Executive Officer of The Center for Cancer and Blood Disorders, an independent medical group community practice based in Dallas/Fort Worth. The Center is a member of OneOncology, a national network of fifteen high-value oncology medical group practices.  Barry has over 30 years of healthcare experience including academic medical center, community practice and community hospital settings.

Barry serves as a Member of the Board of Directors of Community Oncology Alliance (COA) and is a member of the Association of Community Cancer Centers (ACCC), American Society of Clinical Oncology (ASCO) and the Texas Medical Group Management Association (TXMGMA). He holds an MBA from the University of Dallas and resides in Colleyville, Texas. Barry is a Founding Member of the Cancer Business Forum.

Dr. Saulet is passionate about changing how we pay for and deliver cancer care. In her role as Market Vice President of Oncology at Carrum Health, she oversees the Cancer Centers of Excellence program, which connects self-insured employers to high-value cancer care providers.

Prior to Carrum, Deirdre spent ten years at Advisory Board (an independent subsidiary of Optum), where she served as Expert Partner, Practice Manager, and Consultant for the Oncology Roundtable. She managed client relationships and led research on oncology trends and best practices in payment reform, patient experience, and clinical innovations. She received her Bachelor’s of Science from the College of William & Mary and her PhD in Immunology from Duke University. Deirdre is a Founding Member of the Cancer Business Forum.

Mr. Barkley is a healthcare business advisor specializing in the transaction of physician and hospital business relationships, particularly consolidated oncology service lines and cancer centers and in value-based care and alternative payment models in oncology. Ron is the President of the Cancer Center Business Development Group.

Ron served as Executive Director for a regional oncology medical group practice and during his tenure, developed an innovative business model relationship between the practice and Dana Farber Cancer Institute, Boston. He also served as Regional Market Executive for the Chicago-area practices of the McKesson/US Oncology Network and as professional business advisor in oncology practice mergers, acquisitions and oncologist-hospital affiliations in numerous market settings nationally.

Mr. Barkley holds a Master’s Degree in Healthcare Administration and a Law Degree with emphasis in healthcare transactional and regulatory law. He is a member of the State Bar of California; American Health Lawyer’s Association (AHLA) and the Association of Community Cancer Centers (ACCC) and is a Founding Member of the Cancer Business Forum.

Carla is a tenured healthcare executive with expertise in building infrastructure and enterprise growth in the healthcare technology market sector.  As Founder and Chief Executive Officer of Spesana, her motivation to create ground-breaking technology products and innovative market strategies is rooted in the belief every patient deserves the best care available. Carla realized her passion for patient care technology solutions as Director of Product Development and Senior Financial Operations Manager of SOS/ACORN, an oncology research firm and community research network formed by the West Cancer Center, Memphis.

Prior to founding Spesana, Carla served as President of Nantcare, a California-based oncology clinical trials and technology company.  Further, as President and Chief Executive Officer of Altos Solutions, the first web-based oncology electronic medical record and big data company, Carla led its acquisition by to Flatiron Health, a Google-Ventures backed organization that was subsequently acquired by Roche.

A graduate of University of Memphis with a cum laude Master of Science in Psychology, Carla holds patents for machine vision and molecular diagnostic interpretation and serves as a Healthcare Board Member of the Federal Reserve Bank in St. Louis, Missouri, and serves on the Board of Directors of Florence Healthcare.

Alexis Bortniker is a health care transactional lawyer in the San Diego office of Foley & Lardner LLP and is chair of the firm’s health care transaction group. Alexis is a strategic advisor, working with health care providers, payers, private equity companies, and technology companies on joint ventures, mergers and acquisitions, payment structures, and complex business transactions. Alexis has extensive experience in alternative payment models, population health management, risk-based reimbursement systems, and payer/provider alignment. She has significant experience working with providers in Medicare Advantage and CMMI demonstration models. Alexis also advises emerging companies in navigating the move away from direct-to-consumer payment models to third party payment strategies, including commercial payment, direct to employer, centers of excellence and more.

She also has considerable experience in matters involving fraud and abuse compliance, including self-referral and anti-kickback laws, Medicare and Medicaid reimbursement, self-disclosures and overpayments. This experience allows her to provide full-service transactional guidance to health care entities in their transactions. Alexis also works regularly with oncology practices, advising on a variety of developing legal areas, including risk and outcomes-based payment models and joint ventures.

Nina Chavez is Vice President of Customer Experience at Flatiron Health. Nina leads the Flatiron Healthcare (HC) community oncology customer experience from go-live onward, encompassing the Implementation, Optimization, Strategic Partnerships and Projects and Account Management teams. She is a subject matter expert in value-based care and clinical practice transformation.

Nina joined Flatiron in 2020 with 16 years of practice experience at the New Mexico Cancer Center (NMCC). In her previous role as Chief Operating Officer at NMCC, she served on the boards of the Association of Community Cancer Centers and the Coalition of Hematology and Oncology Practices. Additionally, she is a fellow with the American College of Medical Practice Executives.

Nina received a Bachelor of Science and an MBA in Business Administration and Management from the University of Phoenix.

Dr. Hamrick leads a team of physicians, nurses, and informatics specialists who inform the development and applications of the Flatiron HC products and services relied upon by front-line clinicians in hundreds of cancer clinics across the United States.

James also maintains a clinical practice part-time at Kaiser Permanente of Georgia in Atlanta, where he previously served as chief of medical oncology and hematology and was in the private practice of oncology and hematology at Georgia Cancer Specialists. He is on the board of the Georgia Center for Oncology Research and Education and previously served on the Kaiser Permanente National Inter-Regional Cancer Leadership Council and the KP National Cancer Chiefs Council.

Dr. Hamrick received his MD and an MPH in epidemiology from the University of North Carolina at Chapel Hill. He completed his residency and hematology/oncology fellowship at the University of California San Francisco. He is board-certified in internal medicine, medical oncology, and hematology.

Mr. Hennessy is Principal at Valuate Health Consultancy.  Valuate helps people get access to the health care they need by guiding manufacturers in value-strategy optimization and commercialization.

John has been engaged in the delivery of oncology care for more than 20 years with experience in physician practice as well as hospital service lines, in community and academic settings. He served as the Vice President of Health Affairs for Sarah Cannon Cancer Services, a division of Hospital Corporation of America (HCA) focusing on best practices and operational excellence and health reform efforts in oncology and the broader healthcare arena. He was also responsible for the collaboration of physicians, leadership teams, and staff in several HCA oncology markets.

John served as the Executive Director of Kansas City Cancer Centers, a US Oncology Network Practice Affiliate, as well as the Executive Director for the Community Cancer Program of the University of Kansas Medical Center.  Further, John has extensive experience in managed care strategies from both the payor and provider perspectives, including provider network product redesign in the worker’s compensation environment.

John is a member and Ambassador of the American Society of Clinical Oncology (ASCO) and serves on several committees including the Clinical Practice Committee and the Education Committee.  John served on the Payment Reform Task Force that developed ASCO’s Patient-Centered Oncology Payment (P-COP) alternative payment model. He is the Vice President of the Board of Directors of the Young Survival Coalition has formerly served on the Board of Trustees of the Association of Community Cancer Centers and as Executive Director of the Kansas Society of Clinical Oncology. John has co-authored manuscripts published in ASCO’s Journal of Clinical Oncology Practice (JCOP), as well as the Journal of Clinical Ethics. John holds a Master’s Degree in Business Administration from the Fuqua School of Business at Duke University.

Dr. Hertler, as the Chief Medical Officer of New Century Health, is responsible for the advancement of the company’s clinical quality initiatives, value-based strategies and utilization management policies and operations. A board certified oncologist who left clinical practice in 2014, he is a nationally recognized leader in oncology clinical practice. Dr. Hertler was a past member of several American Society of Clinical Oncology committees, including the Clinical Practice, Quality of Care and Payment Reform Committees.

Prior to joining the New Century Health in 2014, Dr. Hertler was the Administrative Medical Director for Physician Practices at Maine General Medical Center and the Medical Director of the Harold Alfond Center for Cancer Care in Augusta, Maine. He is a past president of the Northern New England Clinical Oncology Society. Earlier in his career, Dr. Hertler was Assistant Professor of Medicine in Hematology/Oncology at the Louisiana State University Medical School.

Dr. Hertler received his medical degree from the University of Michigan and completed his residency in Internal Medicine at University of Michigan affiliated hospitals. He later completed a Fellowship in Medical Oncology/Hematology at Duke University Medical Center. He received his bachelor’s degree in chemistry with highest honors from Dartmouth College.

Manasi Kapoor is a Market Insights Manager in Memorial Sloan Kettering’s Office of Technology Development.  She works on the Digital Health team of OTD’s Technology Management and Commercialization unit.

Before joining MSK in 2021, Manasi was a Managing Director at OptumInsight, serving biotech and pharma clients.  Her previous roles include working as a Strategic Consultant with Gartner; as a Senior Consultant at The Advisory Board Company, where she advised senior health system executives on a variety of strategic and operational issues.

Manasi received an MBA degree from Georgetown University, McDonough School of Business, and a BA degree in Economics and Political Science from Macalester College.

Dr. Klein is the Vice President of Medical Affairs for Payor Relations for Tempus, a data driven precision medicine company, providing the world’s largest library of clinical and molecular data.  In this role, he manages the intersection of revenue and claims payment with payor policies, and also participates in the commercial markets strategic initiatives.  Most recently, Ira was the Chief Medical Officer of Health New England, leading the initiatives in medical management, contracting, network integrity, and quality and analytics.

Previously, he was the leader and Senior Director of Healthcare Quality Strategy in the Strategic Customer Group of J&J Health Care Services, building a new quality strategy capability for the Janssen brands.  Prior to that at Aetna, he was the National Medical Director for Clinical Thought Leadership, Chief of Staff to the Chief Medical Officer and founded the Oncology Solutions team that created pathways and medical home value-based arrangements.  He also developed novel wellness and benefit design programs in the large employer segment of Aetna’s National Accounts business.  His earlier career included Assistant Chief Medical Officer of Bayshore Community Health Systems, engaged in all aspects of inpatient and outpatient business, Chief Medical Officer of Elderplan, serving the frail elderly in New York City and building a Part D formulary and benefit design as part of a Medicare Demonstration Project. He practiced Internal Medicine at Robert Wood Johnson Medical School as Assistant Professor of Internal Medicine.

Dr. Klein is an AOA graduate of Robert Wood Johnson Medical School, and completed residency training at Brown University and RWJMS/UMDNJ. As well, Ira holds a Master’s Degree in Business Administration from Rutgers School of Business, and maintains his Board certification in Internal Medicine.  His Bachelor’s Degree is from Rutgers College of Pharmacy with highest honors.  Ira has a personal interest in health information technology and data security, having been previously certified in the medical HIT area.

Dr. Kolodziej is a Senior Advisor at ADVI, a Washington D.C. – based healthcare consulting, strategy and advocacy firm. He also serves as Head of Medical Oncology at Canopy, a firm specializing in oncology electronic patient reported outcomes (e-PROs). Dr. Kolodziej attended Medical School at Washington University in St. Louis and trained in Internal Medicine and Hematology-Oncology at the University of Pennsylvania. He then joined the faculty at the University of Oklahoma Health Sciences Center as an Associate Professor.

Prior to his current roles at ADVI and Canopy, Dr. Kolodziej was a practicing oncologist at New York Oncology Hematology, Albany, New York and was the Chairman of the Pharmacy & Therapeutics Committee and leader in the development and implementation of oncology clinical pathways for the US Oncology Network. Further, Mike has served as National Medical Director Oncology Solutions for Aetna and as a Medical Director for Flatiron Health.

Dr. Levine is President of Health Innovation and Policy for City of Hope, an NCI-designated comprehensive cancer center. He also serves as the Chairman of the Board of AccessHope, a company spun out from City of Hope that is focused on serving the employer market and making leading-edge cancer care available to all regardless of geographical location.

Prior to City of Hope, Dr. Levine held executive roles at UnitedHealth Group, Towers Watson and Anthem Inc. He currently serves as a Board Member of a number of healthcare organizations, including BioScienceLA; Keck Graduate Institute; Vida Health; Active Life Scientific and Reimagine Care.  In addition, Dr. Levine is a member of the Accessibility and Affordability Working Group for California Institute for Regenerative Medicine, a senior fellow for Health Evolution Forum’s New Models of Care Delivery and a long-term strategic advisor to the founder/chairman of the board of Quantum Health.

Dr. Levine is certified by the American Board of Internal Medicine and licensed by the Medical Board of California. He earned his undergraduate degree from Harvard College and his medical degree from the University of California San Francisco. He interned at Mount Zion Hospital and Medical Center in San Francisco and completed his residency in internal medicine at Cedars-Sinai Health System in Los Angeles.

Dr. McAneny is the Chief Executive Officer and founder of New Mexico Oncology Hematology Consultants Ltd, a multispecialty cancer focused physician owned practice and of New Mexico Cancer Center.  She is the Founder and Chair of the Board of the National Cancer Care Alliance, a network of oncology practices focused on sustaining independent practices through collaboration on clinical and health outcomes research, group purchasing and value-based care.

Advocacy is a significant part of Dr. McAneny’s career. She served as President of the American Medical Association in 2018, Chair of the AMA Board in 2015 and served on the AMA Council of Medical Service. She has been on numerous committees at the American Society of Clinical Oncology and served on the ASCO Board of Directors. Dr McAneny is on the Community Oncology (COA) Alliance Board of Directors Executive Committee.

In 2012, she received a $19.8M award from the Center for Medicare and Medicaid Innovation (CMMI). The award funded an initiative called COME HOME, which established the oncology medical home as a method of improving care for patients at a lower cost.

As Founder and a board member of the New Mexico Cancer Center Foundation in 2002 and now on the Board of the Cancer Safety Net Foundation, Dr. McAneny has been addressing the social determinants of health by assisting patients in need with grants for non-medical expenses during therapy.  Dr. McAneny is a Board-Certified Oncologist/Hematologist. Her MD is from the University of Iowa and her fellowship was at the University of New Mexico.

Mr. Mounce is the Chief Executive Officer of Oncology Care Partners (OCP), a transformative provider organization in cancer care designed to provide care exclusively to patients within value-based contracts, Medicare Advantage Plans for example. OCP is focused on disrupting the fee for service status quo in oncology care.

Erich has over 40 years healthcare experience with a unique mix of operational leadership for physician-led care models, ambulatory care delivery settings, and acute care hospital systems. Erich served as the Chief Operating officer of OneOncology, a national network of 15 high-value oncology medical group practices. Prior to OneOncology, he served as the Chief Executive Officer of The West Clinic / West Cancer Center, one of the nation’s top community oncology practices. During his tenure with OneOncology and West Cancer Center, he gained a national recognition for private practice innovation and development of collaborative multidisciplinary operating models with partnerships, such as hospital systems, payers, and participation in early value-based oncology care models.

Prior to his experience in the oncology sector, Mr. Mounce served in a variety of C-suite roles for an acute care hospital company and a physician owned Medicare Advantage plan. Mr. Mounce began his healthcare career with the Los Angeles City Fire Department where he proudly served in the field for a decade as a Senior Fire Paramedic.

Kelley D. Simpson is the President of Cancer Concierge LLC. Kelley has a passion for helping hospitals and physicians drive transformative cancer care delivery. Her strategic, analytical, and operational skills and organizational experience enable her to be a catalyst for change with physician enterprise and ambulatory networks.  Kelley is recognized as an industry leader of business transactions, facilitating hundreds of arrangements among hospitals, health systems, NCI affiliates, and medical groups.

Most recently Kelley served as a Director of Chartis and co-leader of its Oncology Solutions practice. Earlier in her career, Kelley was a Partner at Oncology Solutions and a Vice President at CDP Services.  Kelley regularly contributes to leading industry publications, including her recent articles, “The State of Access and the Healthcare Experience for Patients with Cancer: Results from a National Survey”; “Tackling Cancer Care’s Now, Next, and Beyond”; “Expanding Patient Access to Cancer Care Services”; and, “Painting a Brighter World in Cancer Care”. She is a Director on the Association of Cancer Executives Board and serves on several committees for the organization.

Kelley received her Master of Business Administration in Healthcare Leadership from the University of Tennessee, Knoxville and her Bachelor of Arts in Accounting and Business Administration from Troy University.

For the past two decades, Ed has been a visionary for the creation and evolution of oncology clinical pathways. He is a strong believer in their utility in improving outcomes for patients with cancer. Ed currently serves as Director of Network Development for Elsevier’s ClinicalPath, leading a team that provides oncology pathway solutions to provider practices of all sizes and site of service.

Prior to his current role leading the network development efforts, Ed was the founding software engineer for Via Oncology (which has become ClinicalPath).  He has deep knowledge of healthcare information technologies, analytics, and the root-cause limitations of both. He is a strong patient advocate, believing that patient quality of life, however that patient defines “quality of life”, should remain the principal goal of care. Ed received his Bachelors of Science degree from the University of Pittsburgh in Natural Sciences.

Adria Warren is a healthcare lawyer with the Boston office of the law firm of Foley & Lardner. Adria advises hospitals, providers, and health care enterprises on complex transactions, corporate, and regulatory compliance matters. Her experience includes mergers, acquisitions, joint ventures, and other affiliations and strategic transactions; forming provider groups, networks, and alliances; and advising on fraud and abuse and HIPAA compliance, employment, reporting and disclosure requirements, and marketing compliance. She is a member of the firm’s Health Care and Technology Industry Teams.

Adria brings a wealth of business and transactional experience to assist clients in the health care industry, including providers, medical device companies, life sciences companies, and health care information technology companies. In addition, Adria counsels entrepreneurs and established companies on a wide range of day-to-day legal and business issues from starting-up through going public, including corporate governance issues, securities laws compliance, tax, and employment matters.

With more than 30 years of healthcare experience and as AON’s CEO, Todd is responsible for overseeing AON’s mission, strategy, operations and finances. As President & Chief Operating Officer of AON since its inception in 2017 to 2021, he made significant contributions across practice operations, central ancillaries, information technology and strategy.

In his previous role as Florida Cancer Specialists (FCS) Chief Operating Officer, he was responsible for the day-to-day operations within the corporate office and nearly 100 locations throughout Florida. Prior to his role as COO of FCS in 2011, Todd was Senior Vice President and Chief Information Officer for US Oncology. As part of the senior management team, Todd helped set organizational goals and objectives, oversaw strategic project prioritization, and led tactical execution of company-wide initiatives. He was also responsible for all day-to-day operational aspects of information technology and strategic direction for the information technology needs of the organization. While serving as Senior Vice President and Chief Information Officer, he was named to the Information Week 500 and received the ComputerWorld/IDG Laureate Award, recognizing individuals and organizations that use information technology to benefit society. Todd’s consulting and management experience in healthcare information technology includes positions with Datamedic Corporation (acquired by VitalWorks and later Amicas Corporation), Multum Corporation (acquired by Cerner Corporation), and MedE America (acquired by WebMD and later HLTH Corporation).

Todd received a bachelor’s degree in health policy and administration from Pennsylvania State University.

Dr. Choksi is an Assistant Medical Director of the Medical Oncology Network at UPMC Hillman Cancer Center.  He is a managing partner of his oncology group of 60 medical oncologists, who practice in Western Pennsylvania, Ohio and New York.  He also maintains a part-time clinical practice.

Rushir is the physician liaison between UPMC Health Plan and the Hillman CancerCenter.  He helped develop a shared savings program between his group and the UPMC Health Plan.  He also serves on the P&T committee for the Hillman CancerCenter and UPMC Health Plan.  

Dr. Choksi’s other responsibilities include establishing and maintaining clinical quality initiatives throughout the network to help standardize patient care.  He originally helped develop Via Pathways (now Elsevier ClinicalPath).   

Dr. Choksi received his MD from Wake Forest School of Medicine in Winston-Salem, NC.  He completed his residency and fellowship at the University of Pittsburgh Medical Center.  

Dr. Bobby Green, MD, is a medical oncologist and Thyme Care’s co-founder, president and chief medical officer. Thyme Care is the leading value-based cancer care partner, collaborating with payers and providers to transform the experience and outcomes for individuals living with cancer.

Prior to joining Thyme Care, Bobby was the chief medical officer at Flatiron Health. He practiced medical oncology in West Palm Beach, Fl at Palm Beach Cancer Institute (which became part of Florida Cancer Specialists) from 1999-2021. Bobby received his undergraduate and MD degrees at Duke University and a masters of science in clinical epidemiology and biostatistics at the University of Pennsylvania where he also completed his internal medicine residency and medical oncology fellowship.

Dr. Wilfong, a practicing medical oncologist and hematologist at Texas Oncology for over 20 years, previously served as senior vice president of payer and care transformation at McKesson/The US Oncology Network and is widely recognized as a leader in oncology value-based care.

In his new role as SVP of Value-Based Care at Thyme Care, Dr. Wilfong will be instrumental in advancing Thyme Care’s value-based care strategy and driving practice transformation efforts.

Alti serves as the chief strategy and innovation officer and is responsible for establishing and reviewing strategic priorities and monitoring the execution of the plans. He holds a dual Master of Business and Healthcare Administration degree and is a Certified Six Sigma Black Belt.

Alti is proud of his South Asian heritage and has fond memories of his childhood when he lived in the Middle East in the small country of Kuwait. His career in healthcare started as a mental health case worker, which shaped his career in healthcare administration where he felt there was a tremendous gap between medical interventions and the pursuit of public health goals.

Prior to joining AON, Alti spent 15 years at Oncology Consultants in Houston, Texas, a successful community oncology practice. In this role, he pursued value-based care and continuous operational, cost and quality improvements.
Alti believes that the future of healthcare involves a multidisciplinary and unapologetically collaborative approach, keeping the patient at the center of all decisions.

Having lost family members to cancer, Canopy founder Lavi Kwiatkowsy realized that even though care teams delivered excellent care, better technology could have improved outcomes and prevented personal suffering. This experience gave him the passion to pursue a solution.

In 2018, internationally-recognized leaders in the oncology and health tech spaces joined Lavi to create the first Intelligent Care Platform that—like our name implies—provides oncology practices with the missing layer of intelligent solutions to provide continuous care and support for patients and caregivers throughout their cancer journey. Those same traits also describe our company’s ability to adapt and expand quickly to support a rapidly evolving healthcare environment.